Patent details

EP3453402 Title: REDUCING IMMUNOGENICITY AGAINST FACTOR VIII IN INDIVIDUALS UNDERGOING FACTOR VIII THERAPY

Basic Information

Publication number:
EP3453402
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP181832726
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
REDUCING IMMUNOGENICITY AGAINST FACTOR VIII IN INDIVIDUALS UNDERGOING FACTOR VIII THERAPY
French Title of Invention:
RÉDUCTION DE L'IMMUNOGÉNICITÉ CONTRE LE FACTEUR VIII CHEZ LES INDIVIDUS SOUMIS À UN TRAITEMENT PAR FACTEUR VIII
German Title of Invention:
REDUZIERUNG DER IMMUNOGENITÄT GEGEN DEN FAKTOR VIII BEI PATIENTEN IN EINER FAKTOR-VIII-THERAPIE
SPC Number:

Dates

Filing date:
12/01/2013
Grant date:
21/07/2021
EP Publication Date:
13/03/2019
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
21/07/2021
EP B1 Publication Date:
21/07/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
12/01/2022
Expiration date:
12/01/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
14/07/2021
 
 

Name:
Bioverativ Therapeutics Inc.
Address:
225 Second Avenue, Waltham MA 02451, United States (US)

Name:
Puget Sound Blood Center
Address:
921 Terry Avenue, Seattle, Washington 98104-1256, United States (US)

Inventor

1

Name:
LIU, Tongyao
Address:
United States (US)

2

Name:
JOSEPHSON, Neil
Address:
United States (US)

3

Name:
GLENN, Pierce
Address:
United States (US)

4

Name:
KRISHNAMOORTHY, Sriram
Address:
United States (US)

5

Name:
JIANG, Haiyan
Address:
United States (US)

Priority

1

Priority Number:
201261586103 P
Priority Date:
12/01/2012
Priority Country:
United States (US)

2

Priority Number:
201261668961 P
Priority Date:
06/07/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/21; A61K 38/37; A61K 39/00; A61K 47/68; C12Q 1/68; C07K 14/755; C12Q 1/6883; A61P 37/06;

Publication

European Patent Bulletin

1

Issue number:
202129
Publication date:
21/07/2021
Description:
Grant (B1)

2

Issue number:
202133
Publication date:
18/08/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages